VR Analytical is a leading provider of Extractables and Leachables (E&L) testing to the pharma, biopharma and e-cigarette industries.
VR Analytical has nearly 20 years’ experience serving pharma and biopharma clients globally, supporting them in testing their product and packaging safety prior to market launch.
The acquisition of VR Analytical extends Crawford’s the footprint beyond the UK (Hall Analytical Laboratories, Manchester) and into the US, the largest E&L market. It also expands Crawford’s pharma/biopharma and e-cigarette testing capabilities and deepens their knowledge, expertise and capacity. The combined group will continue to deliver the very best scientific insight, information and support to the Life Sciences, Medical Device and Electronic Nicotine Delivery systems sectors.
Sam Crawford, CEO of Crawford Scientific Group says: “We are delighted to be joined by Ray and the excellent team he has built at VR Analytical. This presents exciting opportunities for our customers in this rapidly expanding and technologically challenging testing market. We have long recognised the strengths of VR Analytical in the quality and capability of their testing, but also in the thought leadership they bring to the industry.”
Scott Fletcher, MD Hall Analytical Laboratories, adds: “We have long admired and respected Ray and his team at VR Analytical and we’re incredibly excited by the opportunities this partnership presents. By combining the best parts of both our organisations we believe we will be able to bring even more compelling solutions, services and thought leadership to the extractable & leachable and ENDS testing sectors.”
Ray Colton, President of VR Analytical, says: “This significant and very carefully considered move will allow VR to invest in our scientific, quality and commercial operations, helping us expand our North American capacity to deliver high quality services to a larger customer base. We are excited to work with Scott and his great team at Hall as we build on our collective expertise across our respective markets.”
